Details for New Drug Application (NDA): 211776
✉ Email this page to a colleague
The generic ingredient in DIFLUPREDNATE is difluprednate. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the difluprednate profile page.
Summary for 211776
Tradename: | DIFLUPREDNATE |
Applicant: | Cipla |
Ingredient: | difluprednate |
Patents: | 0 |
Suppliers and Packaging for NDA: 211776
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DIFLUPREDNATE | difluprednate | EMULSION;OPHTHALMIC | 211776 | ANDA | Cipla USA Inc. | 69097-341 | 69097-341-35 | 1 BOTTLE in 1 CARTON (69097-341-35) / 5 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | EMULSION;OPHTHALMIC | Strength | 0.05% | ||||
Approval Date: | Aug 9, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription